Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.
Cancer. 2005 Sep 1;104(5):1004-12. doi: 10.1002/cncr.21276.
Cancer. 2005.
PMID: 16047333
Free article.
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
Majdak EJ, De Bock GH, Brozek I, Perkowska M, Ochman K, Debniak J, Milczek T, Cornelisse CJ, Jassem J, Emerich J, Limon J, Devilee P.
Majdak EJ, et al.
Eur J Cancer. 2005 Jan;41(1):143-50. doi: 10.1016/j.ejca.2004.10.011.
Eur J Cancer. 2005.
PMID: 15617999
Item in Clipboard
[Hereditary ovarian cancer as a separate clinical entity].
Majdak E, Debniak J, Emerich J.
Majdak E, et al.
Ginekol Pol. 2003 Jul;74(7):557-64.
Ginekol Pol. 2003.
PMID: 14531330
Review.
Polish.
Item in Clipboard
[Lymph node metastasis as a prognostic factor in cervical carcinoma].
Kobierski J, Emerich J, Królikowska B, Majdak E.
Kobierski J, et al.
Ginekol Pol. 2002 Nov;73(11):925-9.
Ginekol Pol. 2002.
PMID: 12722375
Polish.
Item in Clipboard
[Evaluation of surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
Emerich J, Milczek T, Debniak J, Majdak E.
Emerich J, et al.
Ginekol Pol. 2002 Nov;73(11):1103-8.
Ginekol Pol. 2002.
PMID: 12722406
Polish.
Item in Clipboard
[Paclitaxel hypersensitivity reactions in patients with advanced ovarian carcinoma].
Kobierski J, Majdak E, Mielcarek P, Emerich J.
Kobierski J, et al.
Ginekol Pol. 2002 Nov;73(11):1015-20.
Ginekol Pol. 2002.
PMID: 12722392
Polish.
Item in Clipboard
[Comparison of quality of life in patients with advanced ovarian cancer treated with intraperitoneal or intravenous cisplatin and cyclophosphamide as a second line of therapy].
Majdak E, Krasińska L, Mielcarek P, Kobierski J, Kozaka J, Milczek T, Emerich J.
Majdak E, et al.
Ginekol Pol. 2002 Nov;73(11):1096-102.
Ginekol Pol. 2002.
PMID: 12722405
Polish.
Item in Clipboard
Cite
Cite